Back
Autolus Therapeutics PLC Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
48
AUTL
Autolus Therapeutics PLC
Last Price:
3.38
Seasonality Move:
1.34%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing buying pressure, which is a positive indicator for future bullish movement.
Autolus Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Sell |
| 20-day SMA: | 4.14 | Sell |
| 50-day SMA: | 3.98 | Sell |
| 200-day SMA: | 4.61 | Sell |
| 8-day EMA: | 3.73 | Sell |
| 20-day EMA: | 3.96 | Sell |
| 50-day EMA: | 4.01 | Sell |
| 200-day EMA: | 4.19 | Sell |
Autolus Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 34.04 | Sell |
| Chaikin Money Flow: | 647442 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.69 - 4.49) | Sell |
| Bollinger Bands (100): | (3.63 - 4.37) | Sell |
Autolus Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Autolus Therapeutics PLC Stock
Is Autolus Therapeutics PLC Stock a Buy?
- Autolus Therapeutics PLC share price is 3.38 while AUTL 8-day simple moving average is 3.86, which is a Sell signal.
- The stock price of AUTL is 3.38 while Autolus Therapeutics PLC 20-day SMA is 4.14, which makes it a Sell.
- Autolus Therapeutics PLC 50-day simple moving average is 3.98 while AUTL share price is 3.38, making it a Sell technically.
- AUTL stock price is 3.38 and Autolus Therapeutics PLC 200-day simple moving average is 4.61, creating a Sell signal.
AUTL Technical Analysis vs Fundamental Analysis
Sell
48
Autolus Therapeutics PLC (AUTL)
is a Sell
Is Autolus Therapeutics PLC a Buy or a Sell?
-
Autolus Therapeutics PLC stock is rated a Sell
The current Autolus Therapeutics PLC [AUTL] share price is $3.38. The Score for AUTL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Autolus Therapeutics PLC Stock Info
Market Cap:
899.4M
Price in USD:
3.38
Share Volume:
854.62K
Autolus Therapeutics PLC 52-Week Range
52-Week High:
7.45
52-Week Low:
3.06
Sell
48
Autolus Therapeutics PLC (AUTL)
is a Sell
Autolus Therapeutics PLC Share Price Forecast
-
What is the Autolus Therapeutics PLC stock price today?
The Autolus Therapeutics PLC stock price is 3.38 USD today. -
Will AUTL stock go up or go down?
Autolus Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Autolus Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Autolus Therapeutics PLC is overvalued.
Is Autolus Therapeutics PLC Stock a Buy?
- Autolus Therapeutics PLC share price is 3.38 while AUTL 8-day exponential moving average is 3.73, which is a Sell signal.
- The stock price of AUTL is 3.38 while Autolus Therapeutics PLC 20-day EMA is 3.96, which makes it a Sell.
- Autolus Therapeutics PLC 50-day exponential moving average is 4.01 while AUTL share price is 3.38, making it a Sell technically.
- AUTL stock price is 3.38 and Autolus Therapeutics PLC 200-day simple moving average is 4.19, creating a Sell signal.
Fundamental Analysis of Autolus Therapeutics PLC
Is Autolus Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.10 per share.
Technical Analysis of Autolus Therapeutics PLC
Should I short Autolus Therapeutics PLC stock?
- AUTL Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Autolus Therapeutics PLC is a Sell
- Autolus Therapeutics PLC Relative Strength Index (RSI) is 34.04, which suggest Autolus Therapeutics PLC is oversold
- The Bollinger Bands (25) for Autolus Therapeutics PLC is (3.69 - 4.49), which suggest Autolus Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Autolus Therapeutics PLC is (3.63 - 4.37), which suggest Autolus Therapeutics PLC is a Sell
* Autolus Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.